Related Experiment Videos
Cell surface markers in chronic lymphotic leukaemia.
Acta Medica Academiae Scientiarum Hungaricae
|January 1, 1977
Summary
This study found higher B-lymphocyte levels in chronic lymphocytic leukemia (CLL) patients compared to healthy individuals. T-cell proportions were notably low in CLL, with no clear link between markers and clinical presentation.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Chronic lymphocytic leukemia (CLL) is a lymphoid malignancy characterized by the accumulation of malignant B-cells.
- Understanding the immunophenotypic profile of lymphocytes in CLL is crucial for diagnosis and prognosis.
Purpose of the Study:
- To investigate the peripheral lymphocyte population in patients with chronic lymphocytic leukemia using surface marker analysis.
- To compare the proportions of B-lymphocytes and T-cells in CLL patients versus normal controls.
Main Methods:
- Utilized EAC-rosetting and surface-bound immunoglobulin (Ig) assays to identify B-lymphocytes.
- Employed the E-rosette test to quantify T-cell populations.
- Correlated surface marker findings with clinical features of CLL.
Main Results:
- Patients with CLL exhibited a significantly higher proportion of B-lymphocytes compared to healthy controls.
- A markedly reduced proportion of T-cells was observed in CLL patients as indicated by the E-rosette test.
- No significant correlations were found between the identified surface markers and the clinical characteristics of the disease.
Conclusions:
- The immunophenotypic profile in CLL is characterized by an expansion of B-cells and a deficit of T-cells.
- Surface marker analysis in CLL may not directly correlate with clinical manifestations.
- Further research can explore the functional implications of these cellular changes in CLL pathogenesis.